Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized vs Intravenous Colimycin for MDR VAP
NCT02906722Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of colistimethate sodium in ventilator-associated pneumonia (VAP), sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2017; status: terminated.
02
Drugs
colistimethate sodium
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02906722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02906722.